Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy

  • J Med Chem. 1996 Feb 2;39(3):625-56. doi: 10.1021/jm9504722.
R R Wexler  1 ,  W J Greenlee ,  J D Irvin ,  M R Goldberg ,  K Prendergast ,  R D Smith ,  P B Timmermans
Affiliations
  • 1. DuPont Merck Pharmaceutical Company, Wilmington, Delaware, USA.